Home » Marijuana & CBD

Marijuana & CBD

Featured posts

DOT Issues Oral Fluid Specimen Collection Procedures Guidelines

The Oral Fluid Specimen Collection Procedures, together with the 49 CFR Part 40, and the U.S. Department of Transportation Operating Administration rules, provide collectors with the information needed in the performance of their collection duties Click here to view...

NDASA Announces International Day addition to its 2025 Conference & Trade Show

Welcome international attendees! The National Drug and Alcohol Screening Association (NDASA,) in partnership with the International Forum for Drug & Alcohol Testing (IFDAT), is proud to add International Day to its annual Conference & Trade Show in...

30 under 30: Help NDASA identify and celebrate rising stars in the industry

Submit an outstanding young person in the drug and alcohol testing industry In 2025, NDASA will recognize 30 incredible young professionals in our industry aged 30 and under who represent the future of safe workplaces, families and communities. Submissions meeting the...

Podcast: Member's Memo

Updates on relevant industry news, compliance issues, regulatory changes and upcoming events.

All posts

Rescheduling of Marijuana Postponed

Rescheduling of Marijuana Postponed

This week, the Drug Enforcement Administration (DEA) administrator issued a Notice of Hearing that is expected to publish in the Federal Register on Thursday, August 29. (Click here to review the Notice of Hearing) In the document, the DEA announced that a hearing on...